No Data
Yantai Zhenghai Bio-Tech (300653.SZ): Buyback completed, with a total expenditure of 49.9204 million yuan to repurchase 2.3601 million shares.
Gelonghui reported on December 20 that Yantai Zhenghai Bio-Tech (300653.SZ) announced that as of the date of the announcement, the share buyback plan has been fully implemented. To date, the company has repurchased 2.36005 million shares of the company through a dedicated securities account via concentrated bidding, accounting for 1.31% of the company’s total share capital. The highest Fill Price was 24.83 yuan/share, and the lowest Fill Price was 17.90 yuan/share, with a total amount paid of 49.9204 million yuan (excluding transaction costs).
Yantai Zhenghai Bio-Tech (300653.SZ): The company currently has no AI pharmaceutical Business.
On December 17, Glonghui reported that Yantai Zhenghai Bio-Tech (300653.SZ) stated on the investor interaction platform that the company currently has no AI pharmaceutical Business.
Yantai Zhenghai Biotechnology Co., Ltd.'s (SZSE:300653) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
yantai zhenghai bio-tech (300653.SZ): has cumulatively repurchased 0.927% shares
On November 4th, Yantai Zhenghai Bio-Tech (300653.SZ) announced that as of October 31, 2024, the company repurchased 1,668,600 shares through the share repurchase dedicated securities account through centralized competitive trading, accounting for 0.9270% of the total share capital. The highest fill price was 24.83 yuan per share, the lowest fill price was 17.90 yuan per share, and the total amount paid was 34.2793 million yuan (excluding transaction costs).
Why Yantai Zhenghai Biotechnology's (SZSE:300653) Shaky Earnings Are Just The Beginning Of Its Problems
Zhenghai Biotech: Report for the third quarter of 2024
Little Excitement Around Yantai Zhenghai Biotechnology Co., Ltd.'s (SZSE:300653) Earnings As Shares Take 29% Pounding
No Data
